Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRao, S.
dc.contributor.authorAnandappa, G.
dc.contributor.authorCapdevila Castillon, Jaume
dc.contributor.authorDahan, L.
dc.contributor.authorEvesque, L.
dc.contributor.authorKim, S.
dc.date.accessioned2022-09-15T07:07:16Z
dc.date.available2022-09-15T07:07:16Z
dc.date.issued2022-08
dc.identifier.citationRao S, Anandappa G, Capdevila J, Dahan L, Evesque L, Kim S, et al. A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202). ESMO Open. 2022 Aug;7(4):100529.
dc.identifier.issn2059-7029
dc.identifier.urihttp://hdl.handle.net/11351/8196
dc.descriptionInhibidor de PD-L1; Cáncer anal; Retifanlimab
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesESMO Open;7(4)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectAnus - Càncer - Tractament
dc.subjectAnticossos monoclonals - Ús terapèutic
dc.subject.meshAnus Neoplasms
dc.subject.meshCarcinoma, Squamous Cell
dc.subject.meshAntibodies, Monoclonal, Humanized
dc.titleA phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.esmoop.2022.100529
dc.subject.decsneoplasias del ano
dc.subject.decscarcinoma de células escamosas
dc.subject.decsanticuerpos monoclonales humanizados
dc.relation.publishversionhttps://doi.org/10.1016/j.esmoop.2022.100529
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Rao S, Anandappa G] The Royal Marsden, London, UK. [Capdevila J] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Teknon-IOB, Barcelona, Spain. [Dahan L] Hôpital de la Timone, Marseille, France. [Evesque L] Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. [Kim S] Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
dc.identifier.pmid35816951
dc.identifier.wos000829876500002
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple